跳至主要内容
临床试验/NCT02795975
NCT02795975终止不适用

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

Hologic, Inc.18 个研究点 分布在 1 个国家目标入组 1,766 人开始时间: 2016年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Hologic, Inc.
入组人数
1,766
试验地点
18
主要终点
Sensitivity and specificity

研究概览

简要总结

The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The subject is ≥14 years of age at the time of enrollment and is currently sexually active (eg, has had penile/vaginal intercourse within the past 6 months).
  • For subjects under 18 years old, assent of the subject and/or parental/legal guardian permission has been obtained if required by the institutional review board (IRB).
  • The subject and/or legally authorized representative is willing and able to undergo the informed consent process prior to study participation, and:
  • reports symptoms consistent with a suspected STI (eg, abnormal discharge, genital itching, pain/discomfort during sexual intercourse or urination, and/or lower abdominal discomfort); or
  • is asymptomatic and known to be partners with, or a contact of, a person with a confirmed or suspected STI; or
  • is asymptomatic and undergoing screening evaluation for possible STIs; or
  • is asymptomatic and undergoing a routine pelvic examination.

排除标准

  • The subject took antibiotic medications within the last 21 days prior to collection.
  • The subject already participated in the study.
  • The subject has a history of illness that the PI or designee considers could interfere with or affect the conduct, results, and/or completion of the study.

结局指标

主要结局

Sensitivity and specificity

时间窗: Enrollment ongoing until estimated March 2017

次要结局

未报告次要终点

研究者

发起方
Hologic, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验